Report

Global Cancer Gene Therapy Market Size study & Forecast, by Type, by End Use and Regional Analysis, 2022-2029

  • Publish Date: Feb,2023
  • Report ID: 3-2-1481
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Cancer Gene Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Cancer Gene Therapy Market, by Type, 2019-2029 (USD Billion)
1.2.3. Cancer Gene Therapy Market, by End Use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Gene Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Gene Therapy Market Dynamics
3.1. Cancer Gene Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Surging demand for novel cancer therapeutics
3.1.1.2. Rising incidences of cancer globally
3.1.2. Market Challenges
3.1.2.1. High cost is associated with gene therapy
3.1.2.2. Unwanted immune responses
3.1.3. Market Opportunities
3.1.3.1. Increasing technological advancements in cancer gene therapy
3.1.3.2. Growing R&D investments
Chapter 4. Global Cancer Gene Therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Gene Therapy Market, by Type
6.1. Market Snapshot
6.2. Global Cancer Gene Therapy Market by Type, Performance - Potential Analysis
6.3. Global Cancer Gene Therapy Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Cancer Gene Therapy Market, Sub Segment Analysis
6.4.1. Oncolytic Virotherapy
6.4.2. Gene Induced Immunotherapy
6.4.3. Gene Transfer
Chapter 7. Global Cancer Gene Therapy Market, by End Use
7.1. Market Snapshot
7.2. Global Cancer Gene Therapy Market by End Use, Performance - Potential Analysis
7.3. Global Cancer Gene Therapy Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
7.4. Cancer Gene Therapy Market, Sub Segment Analysis
7.4.1. Research Institutes
7.4.2. Biopharmaceutical Companies
7.4.3. Diagnostic Centers
7.4.4. Others
Chapter 8. Global Cancer Gene Therapy Market, Regional Analysis
8.1. Cancer Gene Therapy Market, Regional Market Snapshot
8.2. North America Cancer Gene Therapy Market
8.2.1. U.S. Cancer Gene Therapy Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End Use breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Cancer Gene Therapy Market
8.3. Europe Cancer Gene Therapy Market Snapshot
8.3.1. U.K. Cancer Gene Therapy Market
8.3.2. Germany Cancer Gene Therapy Market
8.3.3. France Cancer Gene Therapy Market
8.3.4. Spain Cancer Gene Therapy Market
8.3.5. Italy Cancer Gene Therapy Market
8.3.6. Rest of Europe Cancer Gene Therapy Market
8.4. Asia-Pacific Cancer Gene Therapy Market Snapshot
8.4.1. China Cancer Gene Therapy Market
8.4.2. India Cancer Gene Therapy Market
8.4.3. Japan Cancer Gene Therapy Market
8.4.4. Australia Cancer Gene Therapy Market
8.4.5. South Korea Cancer Gene Therapy Market
8.4.6. Rest of Asia Pacific Cancer Gene Therapy Market
8.5. Latin America Cancer Gene Therapy Market Snapshot
8.5.1. Brazil Cancer Gene Therapy Market
8.5.2. Mexico Cancer Gene Therapy Market
8.6. Rest of The World Cancer Gene Therapy Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abeona Therapeutics Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Asklepios BioPharmaceutical Inc.
9.2.3. Bluebird bio Inc.
9.2.4. GlaxoSmithKlineInc.
9.2.5. Introgen TherapeuticsInc.
9.2.6. MerckKGaA
9.2.7. BioCancell Inc.
9.2.8. Elevate BioInc.
9.2.9. Genelux Corporation
9.2.10. OncoGenex Pharmaceuticals Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption